Health authorities in Mambwe District are set to start the Mass Drug Administration as measure to treat Lymphatic Filariasis disease also known Elephantiasis.
The District Health Director George Mshanga told ZANIS today that the exercise to administer drugs for treating elephantiasis will run from December 28, 2020 to January 10, 2021.
Dr Mshanga said the exercise is vital for Mambwe District as the area has been identified as one of the red zone districts with a high risk of elephantiasis disease.
“Mambwe is a valley area and very prone to a group of mosquitoes namely Culex and Aedes that are known to cause the named disease. That is the more reason why all eligible persons need to take the drugs if the disease is to be prevented. As you are aware, prevention is better than cure,” he said.
Dr Mshanga estimates that at least 92 percent of the total population in Mambwe will be reached during the mass administration of drugs for elephantiasis.
He further explained that the drugs to be administered namely Albenadzole and Diethylcarbamazine (DEC) will be administered to persons aged two years and above.
“The dosage of the two drugs taken in combination Albenadzole and Diethylcarbamazine will be as follows: persons aged two to four years, two tablets—one tablet of each drug, persons aged five to 14 years, 3 tablets—one tablet Albenadzole and two tablets DEC and persons aged 15 years and above—one tablet Albenadzole and three tablets DEC,” Dr Mshanga explained.
He further explained that the drugs will not be administered to pregnant women, children below the age of two, very sick individuals and persons known to be adversely affected after taking the drugs.
And Dr Mshanga appealed to all residents of Mambwe district to take the drugs in order to control Elephantiasis which is a public health problem.
The Mass Drug Administration for Lymphatic Filariasis is a national programme that is being carried in six other districts.